Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease-Reference-Cited by-同舟云学术

Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease

Published:2012-02-16 Issue:3 Volume:7 Page:479-486
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

Chapman Arlene B.,Bost James E.,Torres Vicente E.,Guay-Woodford Lisa,Bae Kyongtae Ty,Landsittel Douglas,Li Jie,King Bernard F.,Martin Diego,Wetzel Louis H.,Lockhart Mark E.,Harris Peter C.,Moxey-Mims Marva,Flessner Mike,Bennett William M.,Grantham Jared J.

Publisher

American Society of Nephrology (ASN)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference35 articles.

1. Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families.;Dalgaard;Acta Med Scand Suppl,1957

2. Autosomal Dominant Polycystic Kidney Disease

3. Autosomal dominant polycystic kidney disease

4. Volume Progression in Polycystic Kidney Disease

5. Volume Progression in Autosomal Dominant Polycystic Kidney Disease: The Major Factor Determining Clinical Outcomes

Cited by 311 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Classification and segmentation of kidney MRI images for chronic kidney disease detection;Computers and Electrical Engineering;2024-11

2. Biomarkers of Kidney Disease Progression in ADPKD;Kidney International Reports;2024-07

3. Improved predictions of total kidney volume growth rate in ADPKD using two-parameter least squares fitting;Scientific Reports;2024-06-14

4. Urine Osmolality Is a Potential Marker of Longer-Term Efficacy of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis;Kidney360;2024-06-10

5. The utility of serum neutrophil gelatinase‐associated lipocalin level on predicting autosomal dominant polycystic kidney disease progression;Therapeutic Apheresis and Dialysis;2024-05-21